Table 2.
Study | Activity, target group, gender | Age (years) | Training intervention; Duration (weeks), intensity (%), frequency (per week), session duration (min) |
Total-Chol rest (mmol/l or %) | HDL-Chol rest (mmol/l or %) | LDL-Chol rest (mmol/l or %) |
---|---|---|---|---|---|---|
Krustrup et al1 | F, UT, M | 29 | 12; 82%HRmax; 2.3; 60 | 5%↓NS | 8%↑NS | 15%↓*† |
R, UT, M | 31 | 12; 82%HRmax; 2.5; 60 | 7%↓NS | 8%↑NS | 4%↓NS | |
C, UT, M | 31 | No intervention | 0%↔NS | 7%↑NS | 0%↔NS | |
Randers et al8 41 | F, UT, M | 31 | 64; 82%HRmax; 1.3; 60 | 0%↔NS | 8%↑NS | 7%↓NS |
C, UT, M | 32 | No intervention | 2%↑NS | 0%↔NS | 7%↑NS | |
Randers et al38 | F, UT, Mh | 36 | 12; 82%HRmax; 2.2; 60 | 0.1↓NS | 0.0↔NS | 0.4↓*NS† |
C, UT, Mh | 43 | No intervention | 0.1↑NS | 0.1↓NS | 0.1↑NS | |
Krustrup et al15 | F, UT, Ma | 46 | 24; 85%HRmax; 1.7; 60 | – | 8%↓NS | 9%↓NS |
DAG, UT, Ma | 47 | DA on CRF | – | 9%↑NS | 9%↑NS | |
Knoepfli-Lenzin et al22 | F, UT, Mmh | 37 | 12; 80%HRmax; 2.4; 60 | 5%↓* | 8%↑NS | 3%↓NS |
R, UT, Mmh | 36 | 12; 79%HRmax; 2.5; 60 | 2%↓NS | 0%↔NS | 0↔NS | |
C, UT, Mmh | 38 | No intervention | 4%↓NS | 8%↑NS | 3%↓NS | |
Schmidt et al17 | F, UT, Mt | 51 | 24; 82%HRmax; 1.2; 60 | 5%↓NS | 8%↑NS | 11↑NS |
C, UT, Mt | 49 | No intervention | 8%↑NS | 9%↑NS | 9%↑NS | |
De Sousa et al39 | F, UT, Mt+Wt | 61 | 12; 83%HRmax; 3; 40; F+D | 0.6↓*† | 0↔NS | 0.4↓*† |
C, UT, Mt+Wt | 61 | Diet group | 0.4↑NS | 0↔NS | 0.3↑NS |
Changes between pre and post training intervention (unless otherwise stated).
*Significant difference from 0 weeks.
†Significant group difference compared to control.
a, hypertensive participants; C, controls; Chol, cholesterol; CRF; cardiovascular risk factors; DAG, doctor's advice group; F, football; F+D, football+diet group; HDL, high-density lipoprotein; HRmax, maximal heart rate; LDL, low-density lipoprotein; M, men; mh, mildly hypertensive participants; NS, not significant; R, running; t, type 2 diabetics; Total-chol, total plasma cholesterol; UT, untrained; W, women.